Acuitas Investments LLC Sells 74,129 Shares of Arteris, Inc. $AIP

Acuitas Investments LLC lowered its stake in shares of Arteris, Inc. (NASDAQ:AIP) by 82.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,871 shares of the company’s stock after selling 74,129 shares during the period. Acuitas Investments LLC’s holdings in Arteris were worth $160,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Worth Venture Partners LLC increased its position in Arteris by 24.2% in the 3rd quarter. Worth Venture Partners LLC now owns 58,731 shares of the company’s stock valued at $593,000 after buying an additional 11,446 shares in the last quarter. Westerly Capital Management LLC raised its holdings in Arteris by 109.6% during the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after buying an additional 745,000 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in shares of Arteris in the third quarter valued at $113,000. Public Employees Retirement System of Ohio lifted its stake in shares of Arteris by 12.3% in the third quarter. Public Employees Retirement System of Ohio now owns 23,913 shares of the company’s stock valued at $242,000 after buying an additional 2,613 shares in the last quarter. Finally, Integrated Wealth Concepts LLC grew its holdings in shares of Arteris by 38.2% during the third quarter. Integrated Wealth Concepts LLC now owns 31,978 shares of the company’s stock valued at $323,000 after buying an additional 8,833 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Arteris

In other news, Director Saiyed Atiq Raza sold 106,031 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $17.21, for a total value of $1,824,793.51. Following the transaction, the director owned 393,690 shares of the company’s stock, valued at approximately $6,775,404.90. This represents a 21.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO K Charles Janac sold 50,000 shares of the stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $16.58, for a total value of $829,000.00. Following the completion of the sale, the chief executive officer owned 9,419,071 shares in the company, valued at $156,168,197.18. This trade represents a 0.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 596,196 shares of company stock valued at $9,657,120. 33.70% of the stock is currently owned by company insiders.

Arteris Stock Performance

Shares of NASDAQ AIP opened at $15.46 on Wednesday. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $19.85. The stock has a market cap of $702.97 million, a PE ratio of -18.85 and a beta of 1.45. The stock has a fifty day moving average of $15.74 and a 200-day moving average of $14.19.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $20.14 million for the quarter, compared to analysts’ expectations of $18.55 million. On average, sell-side analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Northland Securities set a $24.00 target price on Arteris in a research report on Friday, February 13th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $20.00 target price on shares of Arteris in a research note on Friday, February 13th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $20.17.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.